I did not expect more then this given the earlier notices and the reality of costs . The company has a plan for transformation and that has to remain the focus. Progress with this according to the schedule they provide will make or break the company. especially the August result. That is factored into price already. Given many of us bought in later seems little point selling for fifty or sixty cents. They do detail the Irish regulator is happy with the first steps and do not detail any further issues with it which they are required to do to avoid class actions so they need to keep providing details on each step of progress like this.
- Forums
- ASX - By Stock
- EML
- Ann: FY23 Interim Report and Update on Transformation Strategy
Ann: FY23 Interim Report and Update on Transformation Strategy, page-11
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
71.0¢ |
Change
0.050(7.58%) |
Mkt cap ! $268.6M |
Open | High | Low | Value | Volume |
65.5¢ | 72.0¢ | 65.5¢ | $1.088M | 1.537M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14070 | 70.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
71.5¢ | 5352 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14070 | 0.700 |
2 | 17526 | 0.695 |
7 | 52253 | 0.690 |
2 | 25352 | 0.685 |
2 | 7941 | 0.680 |
Price($) | Vol. | No. |
---|---|---|
0.715 | 5352 | 1 |
0.720 | 112819 | 6 |
0.725 | 38072 | 4 |
0.730 | 109543 | 4 |
0.735 | 13417 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online